Lipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy – part II

Prof. Dr. G. De Rosa1), University Frederico II Naples/Italy

+ Show more

1.

Prof. Dr. Giuseppe De RosaDepartment of Pharmacy, University Federico II of Naples, Via Domenico Montensanto 49, 80131 Naples, Italy

People involved

Prof. Giuseppe De Rosa (gderosa@unina.it) and Dr. Virginia Campani - Department of Pharmacy, University Federico II of Naples

Prof. Michele Caraglia, Dr. Silvia Zappavigna, and Dr. Marianna Abate - Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

Dr. Carlo Leonetti and Dr. Manuela Porru - Department of Research, Diagnosis and Innovate Technologies, Regina Elena National Cancer, Rome, Italy

Abstract

This is a follow-up study. Please refer to the first project.

For short, this research activity should provide the proof-of-principle for using SANPs as delivery system for miRNA in the treatment of brain tumors, thus supporting the further studies.

Results/Outcome

Will be added as soon as available.

Visit the supervisors lab

Contact

Publications derived from the project:
1.
Campani V, Zappavigna S, Scotti L, Abate M, Porru M, Leonetti C, Caraglia M, De Rosa G, 2020
Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA
Int. J. Pharm. (Amsterdam, Neth.) Accepted for publication
previous project
next project